According to a recent case report, a new fluoroscopy-based balloon occlusion technique combined with thrombin injections proved successful in treating complex pseudoaneurysms of the common ...

Thrombosis, the clogging of blood vessels, is a major cause of heart attacks and embolism. Scientists have now engineered the first inhibitors of thrombin, a protease promoting thrombosis, that is ...

An interdisciplinary team of researchers from North Carolina State University and the University of North Carolina at Chapel Hill has developed a smart patch designed to monitor a patient's blood and ...

A pseudoaneurysm (also called a false aneurysm) is a collection of blood and blood clot that has formed outside a blood vessel, usually after an injury. The collection is connected by a channel to the ...

ZymoGenetics Inc. opened a broad Phase II program of recombinant human Thrombin (rhThrombin), which is being developed to control bleeding during surgery. The Seattle-based company began a Phase II ...

After more than 60 years of having only warfarin as an option for oral anticoagulation, several target-specific oral anticoagulants have entered the market. These agents include a direct thrombin ...

Although there is no clinical evidence of a role for the hemostatic system in the progression of atherosclerosis, ample experimental data indicate that platelets and the coagulation system are ...

An advance towards the development of an anti-thrombotic drug by discovering a way to harness the enzyme thrombin's anti-blood clotting properties has been made by molecular biologists. The finding ...